Newsroom - Centogene AG

Press releases

CENTOGENE raises a EUR 25 million Series A financing to fuel innovation and to accelerate growth into personalized medicine

, Medical Technology

- International consortium of investors led by TVM Capital Life Science together with DPE Deutsche Private Equity, Careventures and CIC Capital - CENTOGENE...

CENTOGENE starts HiSeq X® whole genome sequencing (WGS) - first commercial organization in Europe to provide rare disease diagnostic with high-throughput genome analysis

, Medical Technology

CENTOGENE announces today a new sequencing facility for rare hereditary disorders, which will use Illumina's HiSeq X® sequencer. With its wellestablished...

CENTOGENE and Interactive Biosoftware start collaboration on CentoMD® and Alamut® Visual

, Software

Centogene AG (CENTOGENE) and Interactive Biosoftware (IBS) announce to start their collaboration on the integration of CENTOGENE’s unique genomic...

FDNA and CENTOGENE Announce First Grant of Molecular Testing Under the Face2Gene Unknown Forum Grant Program at the American Society of Human Genetics (ASHG) Annual Meeting

, Company-internal

Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics, enabled the first grant...

CENTOGENE's genomic database allows decoding rare genetic information - CentoMD® 3.1 bursts the 100,000 real case line

, Research / Development

With the upcoming release of CentoMD® 3.1 end of September 2016, CENTOGENE will report genetic information and clinical data from more than 100,000...

CENTOGENE drives CentoMD® - the world's largest mutation data base for rare diseases - to the next level

, Software

CENTOGENE AG (“CENTOGENE”) announces the launch of the completely updated CentoMD® 3.0 CentoMD®, the world’s leading proprietary human genetic...

CENTOGENE appoints new CFO, Richard Stoffelen, to take company through next phase of growth

, Company-internal

CENTOGENE AG, a world-leading company in the characterization and diagnostic of rare hereditary diseases, announces the appointment of Richard...

CENTOGENE revolutionizes the clinical interpretation of rare disease genetic variants

, Company-internal

CENTOGENE AG ("CENTOGENE") announces the launch of the world's largest genetic mutation database for rare diseases, CentoMD®. CentoMD­® is...

Centogene announces appointment of new board member

, Company-internal

Dr. Péter Adorján has been appointed to the board of Centogene, extending the board to three members. As Chief Business Development Officer,...

CENTOGENE, Rostock/Freiburg/Vienna based Rare Disease Company, is strengthening senior management team

, Company-internal

Centogene Holding AG announced today that Christine Uekert, formerly executive in IT businesses at SPM Technologies and SAP and Life Science...

Prof. Jürgen Kohlhase New Director Human Genetics of Centogene

, Company-internal

Centogene Holding AG, parent company of a group of diagnostic laboratories, announced today that Prof. Jürgen Kohlhase, MD, Founder of the Center...

Michael Schlenk New Chief Executive Officer of Centogene Holding AG

, Company-internal

Centogene Holding AG (formerly Arcensus AG), parent company of a group of diagnostic laboratories, announced today that Michael Schlenk, former...


Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Centogene AG
Schillingallee 68
D - 18057 Rostock


Frau Doreen Niemann

Senior Director Strategic Communication

Phone +49 381 203652-181
Fax +49 381 20365219

Herr Michael Schlenk


Phone +49 381 203652-0

all contacts

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.